רווח נקי למניה (EPS TTM) Longboard Pharmaceuticals Inc (LBPH)

Longboard Pharmaceuticals (LBPH) serves as a defensive asset due to its sovereign innovation cycle. The rolling specific profit history on GURU.Markets shows that this metric is fixed at -2.25. Business stability is based on independence from macroeconomics and molecule testing phases, while constant demand for epilepsy therapy ensures the company's resilience to market shocks.

This metric recalculates the total net income of Longboard Pharmaceuticals (LBPH) per common share, neutralizing the impact of the issuance volume. It reflects the actual efficiency of profit generation for the shareholder. By analyzing the rolling year earnings per share, one can assess the financial stability of the Longboard Pharmaceuticals (LBPH) clinical trial outsourcing model. Effective control of external laboratories directly determines the dynamics of this indicator. The stability of the metric confirms the investment attractiveness of the asset.